People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aeterna Zentaris Inc. | — | Pharmaceuticals | Series A | $9.5M | $139.4M | 2019 |
Carolyn V. Egbert at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Carolyn V. Egbert on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Leslie Auld | 1 | 2 |
| Gilles Gagnon | 1 | 2 |
| Robin Smith Hoke | 1 | 2 |
| Klaus Paulini | 1 | 1 |
| Nicola Ammer | 1 | 1 |
| Carolyn Egbert | 1 | 1 |
| Gerard Limoges | 1 | 1 |
| Brent Norton | 1 | 1 |
| Michael V. Ward | 1 | 1 |
| Leslie V. Auld | 1 | 1 |
| Klaus V. Paulini | 1 | 1 |
| Brent V. Norton | 1 | 1 |
| Robin V. Smith Hoke | 1 | 1 |
| Gerard V. Limoges | 1 | 1 |
| Nicola V. Ammer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.